DrugDashboards

Granisetron Hydrochloride

Granisetron Hydrochloride · GRANISETRON HYDROCHLORIDE 1 mg/1 · Tablet, Film Coated · Oral · Bionpharma Inc.

NDC 69452-0350-01 · 2 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED in 1 BLISTER PACK · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 20% over the past year, to $1.27 per unit. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Feb 2023Sep 2026$1.27
35 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$38.12
#90 count
$114.37

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$24,158
384 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

28Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 2 active manufacturers+20
  • price down 23% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for granisetron hydrochloride (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA078678
TE code
AB
Approval date
Feb 13, 2008
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Granisetron Hydrochloride (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Bionpharma Inc.GRANISETRON HYDROCHLORIDE 1 mg/1Jul 15, 2026Sep 2, 2026
Natco Pharma LimitedGRANISETRON HYDROCHLORIDE 1 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Granisetron Hydrochloride — NDC 69452-0350-01," retrieved September 3, 2026, https://drugdashboards.com/drug/69452035001.

Free to cite with attribution — see how the data is put together.